Answers are grounded in this paper and cite their sources.
Diagnostic evaluation demonstrates rapid phenotypic antimicrobial susceptibility testing via a nanozyme-driven colorimetric array, highlighting faster clinical decision-making.
. Furthermore, by monitoring real-time changes in catalase activity upon antibiotic exposure, the platform enables phenotypic antimicrobial susceptibility testing (AST) with a rapid assay time of ∼75 min for standardized bacterial suspensions, expediting the evaluation process compared to culture-based methods. Validated in water samples and clinical isolates, the AST results showed good agreement with the clinical laboratory standards institute (CLSI) gold standard. Therefore, this nanozyme-driven, single-probe sensor array provides a sensitive, and cost-effective tool for integrated pathogen identification and rapid AST.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: